Nordson Corporation

Nordson Corporation designs and manufactures precision dispensing, testing, and inspection equipment for industrial applications spanning electronics assembly, medical device manufacturing, and packaging. By FY2019 (fiscal year ending October 31), the company generated $2,194M in revenue with adjusted EBITDA margins of approximately 27% — well above the 15–18% typical of diversified industrial equipment peers. The opportunity lay in applying Nordson's M&A capability to a fragmented landscape of niche industrial equipment makers: hundreds of private companies commanding near-monopoly positions in narrow applications but lacking the scale to invest in global distribution, R&D, or aftermarket infrastructure. Nordson's global distribution and service network spanning 35+ end markets created an integration platform that would be costly for acquirees to replicate independently. The strategic question was whether Nordson could deploy M&A capital at increasing scale — from sub-$200M tuck-ins toward transformative transactions exceeding $800M — without degrading margins or return on invested capital.

Between FY2020 and FY2024, Nordson executed four major acquisitions totaling approximately $2.4B, each filtered through a consistent thesis: target niche market leaders with significant aftermarket or recurring revenue from consumables and spare parts, defensible engineering moats in fluid dynamics or optical sensing, and customer relationships entrenched enough to sustain pricing through economic cycles.

The acquisitions followed deliberate sequencing. In FY2021, Nordson acquired NDC Technologies from Spectris plc for $180M, adding non-contact thickness and profile measurement systems for film, sheet, and foil production — extending Advanced Technology Solutions inspection capabilities from electronics into industrial process control. In August 2022, Nordson acquired CyberOptics Corporation for $380M, bringing 3D precision sensing for semiconductor wafer and component inspection, a segment where customers cannot tolerate measurement errors and switching costs are high. In FY2023, the ARAG Group acquisition (€960M, approximately $1.05B) marked the largest in Nordson's history, entering precision agriculture spraying and fluid management where ARAG held dominant European OEM positions in precision-application spray systems. In FY2024, Nordson acquired Atrion Corporation for approximately $800M, adding medical infusion systems and cardiovascular device components, expanding the Medical and Fluid Solutions segment that Nordson had separated into a standalone reporting unit in August 2022.

Post-acquisition integration followed a preserve-and-connect model: acquired businesses retained their brands, sales forces, and product roadmaps while Nordson layered in its global service network (6,000+ employees across 35+ countries), shared ERP infrastructure, and procurement leverage. Management maintained a strict filter — passing on the majority of deals screened annually — and prioritized proprietary deal sourcing over competitive auctions to avoid paying for strategic optionality that other bidders might price in.

Between FY2019 and FY2024, Nordson grew revenue from $2,194M to $2,690M, a 22.6% increase, while EBITDA expanded 44% from approximately $587M to $849M. EBITDA margins widened from approximately 27% to 32%, a roughly 500 basis point improvement sustained across a period that included the COVID-19 supply chain shock, the semiconductor cycle downturn of FY2023, and commodity cost inflation. This margin expansion is notable because Nordson absorbed $2.4B+ in acquisitions during this window — a level of M&A spending that typically compresses EBITDA margins for 12–24 months post-close in industrial roll-up strategies. The Medical and Fluid Solutions segment, carved out as a standalone reporting unit in August 2022, generated $660M in revenue in its first full reporting year (FY2023), reflecting the scale already embedded in the acquired medical portfolio. By FY2024, Nordson's three-segment structure — Industrial Precision Solutions at $1,484M, Medical and Fluid Solutions at $695M, and Advanced Technology Solutions at $510M — distributed exposure across electronics cycles, medical device demand, and industrial process markets, reducing single-cycle revenue volatility compared to the two-segment configuration of FY2019.

The primary enabler was Nordson's aftermarket revenue architecture. Because acquired businesses generated a significant share of revenue from replacement consumables, spare parts, and service contracts tied to the installed base, acquired EBITDA was significantly more durable than headline multiples implied. This structure allowed Nordson to underwrite deals at 15–16x EBITDA on ARAG and Atrion with confidence that margin improvement would come through global distribution reach rather than through integration-driven cost cuts that might damage customer relationships.

A second enabler was Nordson's existing global service infrastructure — 6,000+ employees in more than 35 countries — which allowed acquired businesses to expand geographically without building their own service networks. ARAG held strong European OEM relationships but limited penetration outside Europe; Nordson's North American and Asia-Pacific distribution provided an immediate revenue expansion path post-acquisition that a standalone ARAG could not have self-funded.

A third enabler was disciplined deal selectivity. Nordson's management has publicly described passing on the majority of acquisition candidates screened annually, filtering for businesses where customer switching costs — embedded in fluid path geometry, calibration protocols, or machine tolerances specific to the acquired product — create structural pricing power that survives under new ownership.

Without the aftermarket revenue composition and global service overlay, the premiums paid on ARAG and Atrion would have been value-destructive. Nordson's ability to expand margins while deploying $2.4B in M&A capital rests on this post-acquisition revenue lift from distribution access, not on financial engineering or cost extraction.